177 related articles for article (PubMed ID: 38514636)
61. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
[TBL] [Abstract][Full Text] [Related]
62. Post-translational modifications of lysine-specific demethylase 1.
Kim D; Nam HJ; Baek SH
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194968. PubMed ID: 37572976
[TBL] [Abstract][Full Text] [Related]
63. The Role of Lysine-Specific Demethylase 1 (LSD1) in Shaping the Endothelial Inflammatory Response.
Wojtala M; Rybaczek D; Wielgus E; Sobalska-Kwapis M; Strapagiel D; Balcerczyk A
Cell Physiol Biochem; 2021 Oct; 55(5):569-589. PubMed ID: 34612026
[TBL] [Abstract][Full Text] [Related]
64. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
Martin KA; Lupey LN; Tempera I
J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
[TBL] [Abstract][Full Text] [Related]
65. The chromatin modifying complex CoREST/LSD1 negatively regulates notch pathway during cerebral cortex development.
Lopez CI; Saud KE; Aguilar R; Berndt FA; Cánovas J; Montecino M; Kukuljan M
Dev Neurobiol; 2016 Dec; 76(12):1360-1373. PubMed ID: 27112428
[TBL] [Abstract][Full Text] [Related]
66. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
[TBL] [Abstract][Full Text] [Related]
67. The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2.
Costa R; Arrigoni G; Cozza G; Lolli G; Battistutta R; Izpisua Belmonte JC; Pinna LA; Sarno S
Biochim Biophys Acta; 2014 Apr; 1844(4):722-9. PubMed ID: 24486797
[TBL] [Abstract][Full Text] [Related]
68. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
Bais MV
J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
[TBL] [Abstract][Full Text] [Related]
69. A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1.
Wirawan A; Tajima K; Takahashi F; Mitsuishi Y; Winardi W; Hidayat M; Hayakawa D; Matsumoto N; Izumi K; Asao T; Ko R; Shimada N; Takamochi K; Suzuki K; Abe M; Hino O; Sekido Y; Takahashi K
Mol Cancer Res; 2022 Jan; 20(1):127-138. PubMed ID: 34593606
[TBL] [Abstract][Full Text] [Related]
70. Lysine-Specific Demethylase 1 (LSD1) epigenetically controls osteoblast differentiation.
Rummukainen P; Tarkkonen K; Dudakovic A; Al-Majidi R; Nieminen-Pihala V; Valensisi C; Hawkins RD; van Wijnen AJ; Kiviranta R
PLoS One; 2022; 17(3):e0265027. PubMed ID: 35255108
[TBL] [Abstract][Full Text] [Related]
71. Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment.
Ma QS; Zhang YF; Li CY; Zhang WX; Yuan L; Niu JB; Song J; Zhang SY; Liu HM
Eur J Med Chem; 2023 May; 251():115228. PubMed ID: 36881982
[TBL] [Abstract][Full Text] [Related]
72. E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC.
Tang F; Lu C; He X; Lin W; Xie B; Gao X; Peng Y; Yang D; Sun L; Weng L
Cell Rep; 2023 Dec; 42(12):113477. PubMed ID: 37979167
[TBL] [Abstract][Full Text] [Related]
73. LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2.
Zhang C; Hoang N; Leng F; Saxena L; Lee L; Alejo S; Qi D; Khal A; Sun H; Lu F; Zhang H
J Biol Chem; 2018 Mar; 293(10):3663-3674. PubMed ID: 29358331
[TBL] [Abstract][Full Text] [Related]
74. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of lysine-specific histone demethylase 1A results in meiotic aberration during oocyte maturation in vitro in goats.
Liu Z; Zhang G; Deng M; Yang H; Pang J; Cai Y; Wan Y; Wang F
Theriogenology; 2020 Feb; 143():168-178. PubMed ID: 31881434
[TBL] [Abstract][Full Text] [Related]
76. Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A).
Li Z; Ding L; Li Z; Wang Z; Suo F; Shen D; Zhao T; Sun X; Wang J; Liu Y; Ma L; Zhao B; Geng P; Yu B; Zheng Y; Liu H
Acta Pharm Sin B; 2019 Jul; 9(4):794-808. PubMed ID: 31384539
[TBL] [Abstract][Full Text] [Related]
77. LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16.
Yin F; Lan R; Zhang X; Zhu L; Chen F; Xu Z; Liu Y; Ye T; Sun H; Lu F; Zhang H
Mol Cell Biol; 2014 Jan; 34(2):158-79. PubMed ID: 24190971
[TBL] [Abstract][Full Text] [Related]
78. Target separation and antitumor metastasis activity of sesquiterpene-based lysine-specific demethylase 1 inhibitors from zedoary turmeric oil.
Ren C; Lin Y; Liu X; Yan D; Xu X; Zhu D; Kong L; Han C
Bioorg Chem; 2021 Mar; 108():104666. PubMed ID: 33550070
[TBL] [Abstract][Full Text] [Related]
79. Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance.
Agboyibor C; Dong J; Effah CY; Drokow EK; Ampomah-Wireko M; Pervaiz W; Sangmor A; Ma X; Li J; Liu HM; Zhang P
Biomed Pharmacother; 2023 Jan; 157():113934. PubMed ID: 36395607
[TBL] [Abstract][Full Text] [Related]
80. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
